Latest filing published 22 Dec 2023 for Genscript Biotech Corporation, €1,110.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Wang Jiafen: trading record in brief
Wang Jiafen appears in our data through filings on Genscript Biotech Corporation shares, published by HKEX. We count 3 filings; the first trade dates from 1 September 2020 and the latest from 20 December 2023.
Both buying and selling appear: 2 purchases, against 1 sale worth €1,110. The totals exclude 2 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show 1 purchase and 1 sale.
The record was last updated on 22 December 2023 with an open-market sale (€1,110) in Genscript Biotech Corporation. The last purchase on record was published on 26 January 2023, which is 1,383 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Wang Jiafen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 470 shares@ HK$20.2238100.0% of flowShareXHKGHKEX:DA20231222E00282
- 14,929 sharesShareXHKGHKEX:DA20230126E00493Canonical exit: 18 Apr 2023 (T+90)
- 270,000 sharesShareXHKGHKEX:DA20200903E00406Canonical exit: 30 Nov 2020 (T+90)
3 of 3 declarations